| Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
Sat/Sunday |
9-12
Team Rounds
3-4PM
Selection Meeting/QAPI
4PM
Signout Rounds
|
8AM
Core/Case Conference
9-12
Team Rounds
2PM
Consult Rounds
4PM
Signout Rounds
|
8AM
Journal Club OR Board Review
9-12
Team Rounds
2PM
Consult Rounds
4PM
Signout Rounds
|
8AM
Tumor Board
9-12
Team Rounds
2PM
Continuity Clinic
4PM
Signout Rounds
5PM
GI/Liver Grand Rounds
|
8AM
Pathology OR Guideline Confernce
9-12
Team Rounds
2PM
Consult Rounds
4PM
Signout Rounds
|
On Call:
9-12
Team Rounds
|
Consult/Outpatient Service Schedule
| Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
Sat/Sunday |
9-12
Transplant Clinic
3-4PM
Selection Meeting/QAPI
|
8AM
Core/Case Conference
9-12
Transplant Clinic
2PM
Consult Rounds
|
8AM
Journal Club OR Board Review
9-12
Transplant Clinic
2PM
Consult Rounds
|
8AM
Tumor Board
9-12
Consult Rounds
1PM
Continuity Clinic
5PM
GI/Liver Grand Rounds
|
8AM
Pathology OR Guidelines Confernce
9-12
Transplant Clinic
2PM
Consult Rounds
|
On Call:
9-12
Team Rounds
|
Fellows may attend specialty office hours, including hepatology, oncology, hepatobiliary surgery, and pediatric liver transplant clinics.
Call Schedule
Hepatology fellows cover two weekend days per month. Additionally, overnight call coverage is shared between hepatology and gastroenterology fellows. The hepatology fellow will take call two nights per week, only covering the inpatient hepatology service, including any incoming admissions or transfers.
Research
All hepatology fellows are encouraged early in their training to identify a project of interest. With a large faculty with diverse research interests available, they will work closely with a research mentor to develop a project with the goal of presenting at a national meeting and publishing in a respected journal.
Recent Publications by Montefiore Fellows & Faculty
Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology. 2021 Jun;73(6):2099-2109. PMID: 33713486; PMCID: PMC8250536.
Andacoglu O, Özbek U, Liu J, Figueredo C, Chacko KR, Tow C, Reinus JF, Kinkhabwala M. Comparison of 1-Year Morbidity Following Liver Transplant for Acute Alcoholic Hepatitis Versus Alcoholic Cirrhosis. Exp Clin Transplant. 2021 May;19(5):439-444. Epub 2021 Jan 11. PMID: 33455569.
Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2021 Jul 15:S1542-3565(21)00749-7. PMID: 34274511; PMCID: PMC8760361.
Frager SZ, Schwartz JM. Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve. Curr Oncol. 2020 Nov;27(Suppl 3):S138-S143. PMID: 33343207; PMCID: PMC7739519.